Publications by authors named "Robert Cotes"

Claim this Profile
A
Absolute neutrophil count and adverse drug reaction monitoring during clozapine treatment: consensus guidelines from a global Delphi panel.
Dan Siskind, Korinne Northwood, Toby Pillinger, Sherry Chan, Christoph Correll, Robert O Cotes

Lancet Psychiatry· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weight change from incretin-based weight loss medications across categories of second-generation antipsychotics.
Jithin Sam Varghese, David R Goldsmith, Robert O Cotes, Vishnu Ravikumar, Mohammed K Ali

Int J Obes (Lond)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perceptions, Use, and Barriers of Clozapine Therapeutic Drug Monitoring in the United States: A Multidisciplinary Survey Study.
Jonathan G Leung, Morgan Gatzlaff, Megan R Leloux, Katelyn N Bye, Jessica Gannon, Robert O Cotes

Ther Drug Monit· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A neutrophil-to-lymphocyte ratio higher than 3 may identify infl ammation during clozapine titrations: A re-analysis of five published cases of myocarditis.
Jose De Leon, Robert O Cotes, David R Goldsmith, Charles Shelton, Betsy McCollum

Neuropsychopharmacol Hung· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A National Analysis of Facility-Level Clozapine Availability in U.S. Mental Health Services.
Samuel R Bunting, Aparna Das, Luca Iacobelli, Emily Griner, Beth Broussard, Robert O Cotes

Psychiatr Serv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring the Unmeasured: U.S. Civil Commitment Rates.
Samuel Dotson, Robert O Cotes, Joseph Stoklosa

Psychiatr Serv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Eliminates the Clozapine REMS-What Comes Next?
Deanna L Kelly, John M Kane, Raymond C Love, Robert O Cotes

JAMA Psychiatry· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in Formulary Restrictions for Long-Acting Injectable Antipsychotic Medications Among Medicare Drug Plans, 2019-2023.
Samuel R Bunting, Robert O Cotes, Kathryn Gray, Kristen Chalmers, Thuy D Nguyen

Psychiatr Serv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing social cognition in psychosis - the potential role of open dialogue.
Maria Gariup, Tomi Bergström, Katharina Saliger, Justin M Palanci, Robert O Cotes

Schizophrenia (Heidelb)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I: A Review of the Pharmacokinetic Literature and Proposed Changes.
Jose de Leon, Ross J Baldessarini, Richard Balon, John Bilbily, Stanley N Caroff, Robert O Cotes

J Clin Psychopharmacol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II: A Review of Fatal Outcomes in US Pharmacovigilance Data and Proposed Changes.
Jose de Leon, Ross J Baldessarini, Richard Balon, John Bilbily, Stanley N Caroff, Robert O Cotes

J Clin Psychopharmacol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A model for timely dissemination of critical information: Clozapine toxicity during the COVID pandemic.
Jessica Gannon, K N Roy Chengappa, Robert O Cotes, Jonathan G Leung, Patrick Frailey

Ment Health Clin· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clozapine's High Incidence of Ileus and Pneumonia Demand Better Clinical Strategies-How Do We Get There?
K N Roy Chengappa, Robert O Cotes

Am J Psychiatry· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postcrisis Follow-Up and Linkage to Community Services.
Alexander McClanahan, Curtis N Adams, Ann L Hackman, Robert O Cotes, Kenneth Minkoff

Psychiatr Clin North Am· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating and mitigating unfairness in multimodal remote mental health assessments.
Zifan Jiang, Salman Seyedi, Emily Griner, Ahmed Abbasi, Ali Bahrami Rad, Robert O Cotes

PLOS Digit Health· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodal Mental Health Digital Biomarker Analysis From Remote Interviews Using Facial, Vocal, Linguistic, and Cardiovascular Patterns.
Zifan Jiang, Salman Seyedi, Emily Griner, Ahmed Abbasi, Ali Bahrami Rad, Robert O Cotes

IEEE J Biomed Health Inform· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of an Open Dialogue-Inspired Approach for Young Adults with Psychosis in a Public Hospital System.
Robert O Cotes, Justin M Palanci, Beth Broussard, Stephanie Johnson, M Alejandra Grullón

Community Ment Health J· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using HIPAA (Health Insurance Portability and Accountability Act)-Compliant Transcription Services for Virtual Psychiatric Interviews: Pilot Comparison Study.
Salman Seyedi, Emily Griner, Lisette Corbin, Zifan Jiang, Kailey Roberts, Robert O Cotes

JMIR Ment Health· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodal mental health assessment with remote interviews using facial, vocal, linguistic, and cardiovascular patterns.
Zifan Jiang, Salman Seyedi, Emily Griner, Ahmed Abbasi, Ali Bahrami Rad, Robert O Cotes

medRxiv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An international research agenda for clozapine-resistant schizophrenia.
Jurjen J Luykx, Jairo M Gonzalez-Diaz, Ta-Wei Guu, Marte Z van der Horst, Edwin van Dellen, Robert O Cotes

Lancet Psychiatry· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Escaping the Long Shadow Cast by Agranulocytosis: Reflections on Clozapine Pharmacovigilance Focused on the United Kingdom.
Jose de Leon, Manuel Arrojo-Romero, Hélène Verdoux, Can-Jun Ruan, Georgios Schoretsanitis, Robert O Cotes

J Clin Psychopharmacol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determining Clinical Follow-Up in the Context of Widening LAI Intervals: How Long Is Too Long?
Samuel J Dotson, Robert O Cotes, Oliver Freudenreich

J Clin Psychiatry· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving clozapine utilization will require continued advocacy, drug sponsor interest, and FDA support to address REMS issues.
Jonathan G Leung, Megan Ehret, Raymond C Love, Robert O Cotes

Expert Rev Clin Pharmacol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should we routinely add CRP to clozapine titrations? - Learning from three cases.
Charles Shelton, Can-Jun Ruan, Aygün Ertuğrul, Robert O Cotes, Jose De Leon

Neuropsychopharmacol Hung· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis